DUKORAL oral inactivated cholera vaccine liquid vial and buffer powder sachet Australia - English - Department of Health (Therapeutic Goods Administration)

dukoral oral inactivated cholera vaccine liquid vial and buffer powder sachet

seqirus pty ltd - vibrio cholerae, quantity: 31.25 billion organisms; vibrio cholerae, quantity: 1 mg - oral liquid, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate dihydrate; water for injections; monobasic sodium phosphate dihydrate - cholera caused by serogroup 01 vibrio cholerae: active immunisation of adults and children from two years of age, who will be visiting areas epidemic or endemic for cholera and who are at high risk of infection.

Magmedi 97 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

magmedi 97 mg tabl.

kora corporation t/a kora healthcare ltd. - magnesium citrate nonahydrate 817 mg - eq. magnesium 97,2 mg - tablet - 97 mg - magnesium nonahydrate 817 mg - magnesium citrate

Magnence 243 mg or. sol. (pwdr.) sachet Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

magnence 243 mg or. sol. (pwdr.) sachet

kora corporation t/a kora healthcare ltd. - magnesium aspartate dihydrate 3246 mg - eq. magnesium 243 mg - powder for oral solution - 243 mg - magnesium aspartate dihydrate 3246 mg - magnesium aspartate

Metaperex 400 IU soft caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

metaperex 400 iu soft caps.

kora corporation t/a kora healthcare ltd. - alfa-tocoferol 280 mg - capsule, soft - tocopherol (vit e)

Dukoral New Zealand - English - Medsafe (Medicines Safety Authority)

dukoral

seqirus (nz) ltd - recombinant cholera toxin b subunit 1mg; vibrio cholerae inaba 48 classical biotype 31250 million organisms (heat inactivated); vibrio cholerae inaba 6973 el tor biotype 31250 million organisms (formalin inactivated); vibrio cholerae ogawa 50 classical biotype 62500 million organisms (equal parts heat inactivated and formalin inactivated) - oral suspension - active: recombinant cholera toxin b subunit 1mg vibrio cholerae inaba 48 classical biotype 31250 million organisms (heat inactivated) vibrio cholerae inaba 6973 el tor biotype 31250 million organisms (formalin inactivated) vibrio cholerae ogawa 50 classical biotype 62500 million organisms (equal parts heat inactivated and formalin inactivated) excipient: dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water for injection citric acid raspberry flavour 52383 ap0551 saccharin sodium sodium bicarbonate sodium carbonate sodium citrate dihydrate citric acid raspberry flavour 52383 ap0551 saccharin sodium sodium bicarbonate sodium carbonate sodium citrate - active immunisation of adults and children from two years of age, who will be visiting areas with an ongoing or anticipated epidemic or who will be spending an extended period of time in areas in which cholera infection is a risk. the vaccine should be considered for foreign aid workers and others intending to visit or spend an extended period of time in areas endemic or epidemic for cholera.

Korandil 5 mg tablets Malta - English - Medicines Authority

korandil 5 mg tablets

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - enalapril maleate - tablet - enalapril maleate 5 mg - agents acting on the renin-angiotensin system

Korandil 20 mg tablets Malta - English - Medicines Authority

korandil 20 mg tablets

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - enalapril maleate - tablet - enalapril maleate 20 mg - agents acting on the renin-angiotensin system

Dukoral European Union - English - EMA (European Medicines Agency)

dukoral

valneva sweden ab - recombinant cholera toxin b subunit, vibrio cholerae 01 - cholera; immunization - vaccines - dukoral is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children from 2 years of age who will be visiting endemic/epidemic areas.the use of dukoral should be determined on the basis of official recommendations taking into consideration the variability of epidemiology and the risk of contracting disease in different geographical areas and travelling conditions.dukoral should not replace standard protective measures. in the event of diarrhoea measures of rehydration should be instituted.

Imunovir 500 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

imunovir 500 mg tablets

kora corporation limited trading as kora healthcare - inosine acedoben dimepranol - tablet - 500 milligram(s) - other antivirals; inosine pranobex